Blog
- Prostate Cancer Xofigo Is A New Drug For Late Stage Prostate Cancer
March 22, 2017
Read MoreProstate Cancer — Xofigo Is A New Drug for Late Stage Prostate Cancer Xofigo is a drug newly approved by the FDA for late stage prostate cancer which has the potential to extend life by about 3 months. The drug treats symptomatic, late-stage, castration-resistant prostate cancer. Xofigo (radium Ra 223 dichloride) is approved for patients who […]
- Cancer Malpractice Lawyer Prostate Cancer
March 22, 2017
Read MoreCancer Malpractice Lawyer — Prostate Cancer There is a new drug therapy that is showing some promise in treating patients with prostate cancer. This new drug therapy involves giving patients a continuous low dose of IL-2, an immune system booster. This type of continuous low dosing is called metronomic dosing. It appears to reduce the […]
- Results Of Study On Treating Heart Attacks To Lower Risk Of Complications
March 22, 2017
Read MoreResults of Study on Treating Heart Attacks to Lower Risk of Complications A study, which was recently published in the New England Journal of Medicine, found that transferring heart attack patients to specialized hospitals to undergo angioplasty within six hours after receiving thrombolytic drugs (clot-busting drugs) reduces the risk of life-threatening complications including repeat heart […]
- Vitamin E And Selenium Dont Reduce Risk Of Prostate Cancer
March 22, 2017
Read MoreVitamin E and Selenium Don’t Reduce Risk of Prostate Cancer The Los Angeles Times reports that Vitamin E and selenium supplements, either taken independently or together, do not reduce a man’s chances of developing prostate cancer, and may even heighten his risks, a federally funded study has found. The National Institutes of Health reported this. […]
- Study Vitamins E And C Fail To Prevent Cancer In Men
March 22, 2017
Read MoreStudy: Vitamins E and C Fail to Prevent Cancer in Men A large clinical trial of almost 15,000 male doctors taking vitamins E and C for up to 10 years has found that neither supplement had any effect on cancer rates, including cancer of the prostate.This new study comes on the heels of a disappointing […]
- Colon Cancer The Second Leading Cause Of Cancerrelated Death In United States Today
March 22, 2017
Read MoreColon cancer the second leading cause of cancer-related death in United States today Colorectal cancer is the second leading cause of cancer-related death in the United States. According to the American Cancer Society, 49,960 people are expected to die in 2008 from colorectal cancer. Excluding skin cancers, colorectal cancer is also the third most common […]
- Study Shows Longterm Health Problems From Contrastinduced Medical Imaging Procedures
March 22, 2017
Read MoreStudy Shows Long-Term Health Problems From Contrast-Induced Medical Imaging Procedures According to a study to be published in a future issue of the Clinical Journal of the American Society Nephrology, kidney injuries can arise following certain medical imaging procedures, which can increase a patient’s risk of having a stroke or heart attack. The results of […]
- Cardiologists May Be Misinterpreting Echocardiograms
March 22, 2017
Read MoreCardiologists may be misinterpreting echocardiograms A study has shown widespread errors by cardiologists in reading echocardiology results and linked these mistakes to insufficient training. In the study, sonography specialists reviewed cardiologists’ interpretations of echo tests and found major errors in 29% of all cases. Physician training appeared to play an important role, since both the […]
- Calcium Channel Blockers Dont Mix With Plavix
March 22, 2017
Read MoreCalcium Channel Blockers Don’t Mix with Plavix A new study says calcium channel blocker drugs, which are widely prescribed for coronary conditions, might reduce the effect of Plavix. Calcium channel blockers are commonly prescribed for high blood pressure and angina. Plavix is a drug prescribed to prevent clots in the arteries. In particular, Plavix (clopidogrel) […]
- Gardasil Cervical Cancer Vaccine Evaluated In New Study
March 22, 2017
Read MoreGardasil Cervical Cancer Vaccine evaluated in New Study 100% of cervical cancers are caused by high risk types of human papillomavirus (HPV). HPV types 16 and 18 cause approximately 70% of cervical cancer cases throughout the world. In 2006 a vaccine called Gardasil, manufactured by Merck, was approved for use in the United States. Gardasil […]